Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 125 of 2228 entries
View as:

An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT00982735 Org: User:
Start: 09/30/07 End: - Due: -

Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02264158 Org: User:
Start: 09/30/01 End: - Due: -

Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01897597 Org: User:
Start: 07/31/13 End: 09/30/13 Due: 09/30/14

Rt-PA in the Treatment of Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00153036 Org: User:
Start: 04/30/03 End: - Due: -

Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02262585 Org: User:
Start: 07/31/02 End: - Due: -

A Study About How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated in Healthy Japanese Men

Phase: N/A Priority: Normal
NCT ID: NCT03875001 Org: User:
Start: 03/25/19 End: 07/20/19 Due: 07/20/20

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BEA 2180 BR in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02254122 Org: User:
Start: 05/31/04 End: - Due: -

Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01619085 Org: User:
Start: 06/06/12 End: 02/01/21 Due: 02/01/22

Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT05503030 Org: User:
Start: 12/21/22 End: 12/30/26 Due: 12/30/27

A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking

Phase: N/A Priority: Normal
NCT ID: NCT03958071 Org: User:
Start: 02/01/19 End: 05/31/19 Due: 05/31/20

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

Phase: N/A Priority: Normal
NCT ID: NCT01438814 Org: User:
Start: 11/30/11 End: 03/31/13 Due: 03/31/14

Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan

Phase: N/A Priority: Normal
NCT ID: NCT04559581 Org: User:
Start: 10/02/20 End: 01/22/25 Due: 01/22/26

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

Phase: N/A Priority: Normal
NCT ID: NCT01131676 Org: User:
Start: 07/31/10 End: 04/30/15 Due: 04/30/16

Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03151499 Org: User:
Start: 05/30/17 End: 07/11/17 Due: 07/11/18

Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02253823 Org: User:
Start: 12/31/01 End: - Due: -

Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02183129 Org: User:
Start: 04/01/99 End: - Due: -

Drug Use Survey of RESPIMAT in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT01145053 Org: User:
Start: 05/31/10 End: 12/31/11 Due: 12/31/12

Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin

Phase: N/A Priority: Normal
NCT ID: NCT01304329 Org: User:
Start: 02/28/11 End: - Due: -

Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib

Phase: N/A Priority: Normal
NCT ID: NCT00993499 Org: User:
Start: 10/31/09 End: 09/30/14 Due: 09/30/15

Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics

Phase: N/A Priority: Normal
NCT ID: NCT00268866 Org: User:
Start: - End: 01/31/07 Due: 01/31/08

Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02629965 Org: User:
Start: 02/12/16 End: 04/17/17 Due: 04/17/18

Safety, Tolerability and Pharmacokinetics of BI 1026706 in Healthy Chinese and Japanese Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02652416 Org: User:
Start: 09/16/16 End: 12/09/16 Due: 12/09/17

BIBW 2992 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02171650 Org: User:
Start: 12/01/04 End: - Due: -

Bioequivalence of IVAX Warfarin Tablets and Coumadin Brand Warfarin Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171494 Org: User:
Start: 09/30/08 End: - Due: -

Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01638598 Org: User:
Start: 07/31/12 End: 08/31/12 Due: 08/31/13